Cancer Research: RGCC Greece Test & Cancer Stem Cells
STEP ONE
Be informed. Read information below.
STEP TWO
Schedule test & interpretation with R. Douglas Wichman, MD.
STEP THREE
Submit "New Patient Form", current labwork, & imaging results prior to interpretation.
STEP FOUR
Establish if you are a candidate for therapy
in accordance with the Georgia
"Access to Medical Treatment Act".
--------------------------------------------------------------------------------------------------------------------------------
*** SPECIAL NOTE FROM DR. WICHMAN ***
WE OFFER THIS TEST to evaluate your Intravenous (IV) therapy options. Beware of certain other doctors who use this test to "sell you supplements". In a real human, ORAL supplementation cannot achieve the tissue concentration necessary to kill cancer cells. By challenging your cancer but failing to kill it, these other doctors are in fact promoting resistance to their own therapy!
----------------------------------------------------------------------------------------------------------------------------------------------------------
Using the latest breakthroughs in molecular biology, The Greece Test can test the blood for malignant tumor cells and assess the patient’s sensitivity to chemotherapy.
The Greece Test Benefits:
- Studies cancer cells without invasive biopsy procedures.
- Tests are performed on the cancer cells themselves, not a subclone.
- Tests the viability of anti-cancer chemotherapy drugs and the patient’s ability to metabolize them.
- Identifies cancer cell mutations that can cause resistance to therapies.
- Testing of natural substances which may be used to support conventional oncology treatments.
Since the Human Genome Project sequenced human DNA, many in the medical community hoped this breakthrough could help diagnose and treat common human diseases, like cancer. Fortunately, new cancer tests have arrived which can help doctors develop a precise treatment.
Using the latest breakthroughs in genetic therapy, The Greece Cancer Test can be used to isolate tumor cells in the bloodstream, culture them for further diagnosis, assess the patient’s sensitivity to chemotherapy, and then develop a profile of the cancer. Using those results, a personalized treatment program can be designed for the individual patient, instead of using a “hit-and-miss” approach using known cancer drugs.
How The Greece Test Works:
In addition, these circulating tumor cells can be used to assess the patient’s ability to metabolize chemotherapy drugs and assess the tumor’s resistivity to treatment. Their result is a more informed treatment procedure crafted for the patient.
Cancer cells travel the circulatory system along with the other blood cells. A medical professional takes a blood sample in the office. The sample is then sent to R.G.C.C. International GmbH, a European genetic research center. They create blood culture and isolate the tumor cell and perform a series of tests are given such as micro-array, PCR, RT-PCR, southern and less northern blot.
Based on the results, the medical practitioner can do the following:
- Discover genes which aid cancer growth.
- Assess which mechanisms that causes the body to resist chemotherapy drugs, and seek chemotherapy drugs that can aid the patient’s recovery.
- Assess which nutrients can cause apoptosis, tumor cell death, and slow cancer cell growth.
- Develop a natural treatment program to hasten recovery.